If approved by the medicines regulator Swissmedic, it would be the first protein-based vaccine to be made available in the country.
Because Novavax has no physical presence in Switzerland, it must apply for authorisation through the Swiss-based distributor Future Health.
Nuvaxovid has been approved for use in the EU by the European Medicines Agency (EMA). The Swiss application must be based on the same documents that were formerly submitted to the EMA.
The process “is intended to help ensure that medicines that are already authorised abroad can be made available to patients in Switzerland as quickly as possible”, said a Swiss government press releaseExternal link on Monday.
Nuvaxovid contains the coronavirus spike protein, which trains the body to identify the virus and swiftly produce antibodies. The vaccine can be stored in conventional fridges for up to six months.
Swissmedic has to date approved mRNA vaccines from Pfizer/BioNTech and Moderna plus the viral vector alternative from Johnson & Johnson for use in Switzerland.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland backs mRNA vaccine for booster jabs
This content was published on
Swiss teenagers, aged 12 to 15, and people who received initial doses of Janssen vector viral vaccine are advised to take a mRNA booster jab.
Covid vaccines: how to end the wait for billions of people
This content was published on
A waiver on intellectual property rights could be the key to getting more Covid drugs and vaccines to the developing world. But it's controversial.
Swiss regulator approves Pfizer/BioNTech booster for 16 and up
This content was published on
Swissmedic has approved the extension of Covid-19 boosters to all people 16 years of age and over for the Pfizer/BioNTech vaccine.
Vaccine alternative has limited impact on Covid campaign
This content was published on
The offer of a non-mRNA Covid vaccine in Switzerland has failed to speed up the government’s vaccination campaign, experts say.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.